Following miR-16-5p overexpression in human embryonic stem cells, exosomes might deliver it to HG-treated podocytes, reducing the degree of podocyte apoptosis and expressing VEGF, thereby delaying the occurrence and development of DN (84). The gene discussed is VEGFA; the disease is liver dysplastic nodule.